Print Page | Sign In | Join Today
News & Press: Company News

HemoShear Co-Founder Testifies on Tech Transfer at Congressional Hearing

Monday, August 19, 2013  
Share |

Dr. Brian R. Wamhoff, co-founder of HemoShear, was the only industry representative invited to present his recommendations on improvements to the U. S. government's Small Business Technology Transfer program to stimulate translation of new discoveries from academia to the marketplace.  Dr. Wamhoff's testimony was given at a hearing of the U.S. House of Representatives Committee on Science, Engineering and Technology for the purpose of guiding the draft of new legislation entitled "Innovative Approaches to the Technology Transfer Act of 2013".


"Having transitioned recently from academic researcher to entrepreneur, I benefitted from the creativity and resources that academic environments provide, while also encountering cultural challenges of translating a new technology from a university lab to a commercial enterprise.  My fellow academic researchers would benefit from appropriate incentives to translate their science, yet at the same time they need structure and accountability," said Dr. Wamhoff.


The draft legislation, supported by Wamhoff will create a program to incentivize research institutions to implement innovative approaches to technology transfer to achieve better outcomes.  The legislation would dedicate a portion of STTR program funding to provide grants to research institutions to help facilitate and accelerate the transfer of federally funded research and technology into the marketplace.


Dr. Wamhoff's testimony and further information on the Committee's activities regarding the Small Business Technology Transfer program may be found at the following locations:



Our Sponsors

Sign up for our newsletter
800 E. Leigh St.  |  Richmond, Va 23219-1534  |  PH: 804.643.6360  |  Email Us
Stay Connected